SINGAPORE - A dermatitis cream that contains two potent medicinal ingredients has been ordered off the shelves, said the ...

Pi De Kang Dermatitis Cream, imported by Da Zhong Tang and supplied by Chinese Medical Centre, was found to contain the ...

New data highlight efficacy, safety, and time off treatment with as-needed ruxolitinib cream in pediatric atopic dermatitis.

The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...

Results showed that Vtama cream 1% was safe, effective and well tolerated in a phase 3 study evaluating the cream in adults and children aged as young as 2 years with atopic dermatitis, Dermavant ...

Arcutis Biotherapeutics reports positive data on ZORYVE cream for atopic dermatitis and foam for psoriasis at AAD 2025. Quiver AI Summary. Arcutis Biotherapeutics, Inc. announced positive new data ...

IVOSKIN, a science-driven skincare brand, officially launched its "Intensive Cica Repair Cream" in January, targeting ...

Key takeaways: Roflumilast cream 0.15% showed rapid itch reduction within 24 hours of first application. More than 40% of patients treated with roflumilast cream achieved EASI 75 by week 4.

Zoryve (roflumilast) cream 0.15% is now available for the topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 6 years of age and older.

Efficacy and Tolerability of Roflumilast Cream 0.15% for Atopic Dermatitis: Pooled Subgroup Analysis of Patients with Face/Eyelid Involvement from Phase 3 INTEGUMENT-1/2 Trials Simpson, E et al.

Once-daily roflumilast cream at 0.15% improved symptoms of atopic dermatitis (AD) across multiple end points. According to investigators of the phase 3 studies that uncovered the findings ...

WILMINGTON, Del., June 20, 2025--Update on FDA Review of Ruxolitinib Cream (Opzelura) for Children Ages 2-11 with Atopic Dermatitis. WILMINGTON, Del., June 20, ...